Page URL:

Ex-US lab owner pleads guilty to selling stem cells

30 August 2011
Appeared in BioNews 622

A US businesswoman from Arizona has been convicted of selling unapproved stem cells over a period of several months.

Fredda Branyon, the former owner of Global Laboratories, pleaded guilty and admitted the stem cells were manufactured without the necessary approval from the US Food and Drug Administration Authority (FDA).

To create the stem cells, Branyon purchased umbilical cords from a midwife in Texas who told parents that their babies' tissue would be donated. Branyon then hired a researcher to extract the stem cells which were sold to an unnamed buyer, who claimed to be a physician and a stem cell research director at a medical school, the plea-bargain states.

The stem cells were then transported to that buyer labelled as products to be used for research only, although Branyon admitted in court she knew they would be used in humans. Prosecutors believe the stem cells were used to treat patients with chronic illnesses.

Branyon was accused of intentionally risking the public's health for profit, which stands at $300,000. She was charged with one count of conspiracy, ten counts of mail fraud using non-FDA-approved drugs and one count of introducing an unapproved new drug into interstate commerce.

Under federal law, stem cells for use in humans are treated as controlled drugs and must receive regulatory approval. 'There are very, very specific rules regarding your ability to do things in terms of clinical use of a cell therapy', said Charles Cox, professor of paediatric surgery at the University of Texas and director of paediatric trauma at the Children's Memorial Hermann Hospital, Texas.

Commenting on the case, Professor Cox, who is exploring experimental stem cell therapies through FDA-approved clinical trials, said the use of non-FDA approved stem cells in humans was 'illegal, unsafe, and probably biologically invalid'. He said that he had not heard of a black market trade in umbilical cords to produce stem cells until now.

Branyon, who has agreed to cooperate with the ongoing investigation, has now been released on bail until she is sentenced in November. She faces a three-year prison sentence and a fine of up to $10,000.

Arizona Woman Pleads Guilty to Selling Unapproved Stem Cells in Valley
KRGV |  20 August 2011
Ex-lab owner convicted of stem cell-related counts
Houston Chronicle |  19 August 2011
Shipping stem cells leads to conviction
Brownsville Herald |  18 August 2011
Stem cell case could land woman in prison
Houston Chronicle |  23 August 2011
21 September 2015 - by Paul Waldron 
The Food and Drug Administration must do more to control clinics offering unproven stem cell treatments in the USA, say scientists....
7 January 2013 - by Dr Linda Wijlaars 
Bone fragments were removed from the eyelid of a woman after a facelift that used her own stem cells yielded some unexpected results...
16 July 2012 - by Cait McDonagh 
Six patients in California, USA, are suing a South Korean company and others for allegedly misleading them about the benefits of stem cell treatments sold to them...
6 February 2012 - by Dr Maria Botcharova 
A clinic in California has announced that its doctors are licensed and trained to carry out a stem cell treatment for chronic pain. Meanwhile, the US Food and Drug Administration (FDA) is pursuing a lawsuit against Regenerative Sciences, the company that developed the technique...
9 January 2012 - by Oliver Timmis 
A professor of pathology and a midwife have been arrested in the US, charged with illegally supplying stem cells for unauthorised use. They are suspected of belonging to a team of at least four people who sold untested stem cell 'cures' to cancer patients and people with neurodegenerative diseases...
11 April 2011 - by Nishat Hyder 
The American states of Minnesota and Oklahoma are both in the process of passing legislation that will criminalise certain embryonic stem (ES) cell research procedures....
28 September 2009 - by MacKenna Roberts 
Banking a newborn's umbilical cord blood through a private company so that stem cells may be derived and stored for that child's or sibling's future medical uses is not financially worthwhile, according to a study performed at the University of California San Francisco (UCSF). It found that the chances of privately stored umbilical cord blood being therapeutic in the next twenty years are so remote that it does not justify the expense. The researchers calculated that it costs ap...
3 August 2009 - by Ben Jones 
Two Israeli doctors and one Romanian are being detained by a special Romanian investigative police unit after raids on a Romanian IVF clinic suspected to be involved in international human egg and stem-cell trafficking. The Romanian department for fighting organized crime (DIICOT) announced in a statement that 'the group was focusing on identifying foreign couples eager to resort to assisted reproduction techniques and on grabbing Romanian (women) aged 18-30 to donate ova for 800 to 1,000 lei...
23 October 2007 - by Antony Starza-Allen 
A provision contained in a US Senate appropriations bill that would have expanded federal funding for human embryonic stem (ES) cell research has been dropped after President Bush threatened to veto the legislation. Senators Tom Harkin and Arlen Specter said that they were willing to 'compromise' and...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.